Factors related to a non-localising technetium 99m sestamibi scan result during parathyroid adenoma imaging in primary hyperparathyroidism.
adenoma/diagnostic imaging
adenoma/surgery
calcium/blood
hyperparathyroidism/surgery
parathyroid hormone/blood
parathyroid neoplasms/surgery
technetium tc 99m sestamibi
Journal
Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery
ISSN: 1749-4486
Titre abrégé: Clin Otolaryngol
Pays: England
ID NLM: 101247023
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
23
04
2020
revised:
12
07
2020
accepted:
15
11
2020
pubmed:
2
12
2020
medline:
15
12
2021
entrez:
1
12
2020
Statut:
ppublish
Résumé
The aim of this study is to investigate factors that are associated with having a non-localising A retrospective study was performed on patients that underwent parathyroid surgery performed within a single institution between 2001 and 2018. Single tertiary centre for parathyroid surgery. 230 patients underwent surgery for primary hyperparathyroidism due to a solitary parathyroid adenoma and had preoperative Variables including age, gender, intra-operative location of parathyroid adenoma, adenoma weight and pre- and postoperative calcium and parathyroid hormone levels were investigated through univariate and multivariate analysis to identify any association with having a non-localising (negative) Multivariate analysis identified that right-sided adenomas (P = .038), superior adenomas (P = .042) and a lower preoperative PTH level (P = .034) were all individual factors associated with having a negative Factors that were associated with having non-localising
Substances chimiques
Technetium Tc 99m Sestamibi
971Z4W1S09
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
357-362Informations de copyright
© 2020 John Wiley & Sons Ltd.
Références
Madkhali T, Alhefdhi A, Chen H, Elfenbein D. Primary hyperparathyroidism. Turkish J Surg. 2016;32:58-66.
Barczyński M, Bränström R, Dionigi G, Mihai R. Sporadic multiple parathyroid gland disease-a consensus report of the European Society of Endocrine Surgeons (ESES). Langenbeck Arch Surg. 2015;400:887-905.
Shane E. Clinical review 122: Parathyroid carcinoma. J Clin Endocrinol Metab. 2001;86:485-493.
Marcocci C, Cetani F, Rubin MR, Silverberg SJ, Pinchera A, Bilezikian JP. Parathyroid carcinoma. J Bone Miner Res. 2008;23:1869-1880.
Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg. 2016;151:959-968.
Sugarman JA, Douglass AM, Say EAT, Shields CL. Stones, bones, groans, thrones, and psychiatric overtones: Systemic associations of sclerochoroidal calcification. Oman J Ophthalmol. 2017;10:47-49.
Bilezikian JP, Brandi ML, Eastell R, et al. Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop. J Clin Endocrinol Metab. 2014;99:3561-3569.
Noureldine SI, Gooi Z, Tufano RP. Minimally invasive parathyroid surgery. Gland Surg. 2015;4:410-419.
Starker LF, Fonseca AL, Carling T, Udelsman R. Minimally invasive parathyroidectomy. Int J Endocrinol. 2011;2011:206502.
Coakley AJ, Kettle AG, Wells CP, O’Doherty MJ, Collins RE. 99Tcm sestamibi-a new agent for parathyroid imaging. Nucl Med Commun. 1989;10:791-794.
Assante R, Zampella E, Nicolai E, et al. Incremental Value of Sestamibi SPECT/CT Over Dual-Phase Planar Scintigraphy in Patients With Primary Hyperparathyroidism and Inconclusive Ultrasound. Front Med. 2019;6:164.
Raruenrom Y, Theerakulpisut D, Wongsurawat N, Somboonporn C. Diagnostic accuracy of planar, SPECT, and SPECT/CT parathyroid scintigraphy protocols in patients with hyperparathyroidism. Nucl Med Rev Cent East Eur. 2018;21:20-25.
Yeh R, Tay Y-KD, Tabacco G, et al. Diagnostic Performance of 4D CT and Sestamibi SPECT/CT in Localizing Parathyroid Adenomas in Primary Hyperparathyroidism. Radiology. 2019;291:469-476.
Cheung K, Wang TS, Farrokhyar F, Roman SA, Sosa JA. A meta-analysis of preoperative localization techniques for patients with primary hyperparathyroidism. Ann Surg Oncol. 2012;19:577-583.
Elaraj DM, Sippel RS, Lindsay S, et al. Are additional localization studies and referral indicated for patients with primary hyperparathyroidism who have negative sestamibi scan results? Arch Surg. 2010;145:578-581.
Khorasani N, Mohammadi A. Effective factors on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism. Int J Clin Exp Med. 2014;7:2639-2644.
Stephen AE, Roth SI, Fardo DW, et al. Predictors of an accurate preoperative sestamibi scan for single-gland parathyroid adenomas. Arch Surg. 2007;142:381-386.
Taterra D, Wong LM, Vikse J, et al. The prevalence and anatomy of parathyroid glands: a meta-analysis with implications for parathyroid surgery. Langenbeck’s Arch Surg. 2019;404:63-70.
Rodríguez-Carranza S, Cáceres M, Aguilar-Salinas CA, et al. Localization of parathyroid adenomas by (99m)Tc-sestamibi scanning: upper neck versus lower neck lesions. Endocr Pract. 2004;10:472-477.
Merlino JI, Ko K, Minotti A, McHenry CR. The false negative technetium-99m-sestamibi scan in patients with primary hyperparathyroidism: correlation with clinical factors and operative findings. Am Surg. 2003;69:225-229.
Gunasekaran S, Wallace H, Snowden C, Mikl D, England RJA. Parathyroid ectopia: development of a surgical algorithm based on operative findings. J Laryngol Otol. 2015;129:1115-1120.
Krčálová E, Horáček J, Nováková E, et al. Dual Tracer 99mTc-Pertechnetate/99mTc-MIBI Dual-Time-Point SPECT/CT Parathyroid Gland Assessment Regarding to Parathyroid Gland Size and Biochemical Parameters - Two Years Single Imaging Centre Experience. Acta medica (Hradec Kral). 2019;62:1-5.
Schachter PP, Issa N, Shimonov M, Czerniak A, Lorberboym M. Early, postinjection MIBI-SPECT as the only preoperative localizing study for minimally invasive parathyroidectomy. Arch Surg. 2004;139:433-437.
Qiu Z-L, Wu B, Shen C-T, Zhu R-S, Luo Q-Y. Dual-phase (99m)Tc-MIBI scintigraphy with delayed neck and thorax SPECT/CT and bone scintigraphy in patients with primary hyperparathyroidism: correlation with clinical or pathological variables. Ann Nucl Med. 2014;28:725-735.
Hoang TD, Jani AG, Mai VQ, Tuamokumo FO, Shakir MKM. Associations of serum ionized calcium, phosphate, and PTH levels with parathyroid scan in primary hyperparathyroidism. Endocr Pract. 2019;25:16-22.